These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 7856090
1. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators. Madore SJ, Cullen BR. Virology; 1995 Feb 01; 206(2):1150-4. PubMed ID: 7856090 [Abstract] [Full Text] [Related]
2. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Chang LJ, Zhang C. Virology; 1995 Aug 01; 211(1):157-69. PubMed ID: 7645208 [Abstract] [Full Text] [Related]
3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B. Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770 [Abstract] [Full Text] [Related]
5. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR. Harhaj E, Blaney J, Millhouse S, Sun SC. Virology; 1996 Feb 01; 216(1):284-7. PubMed ID: 8615004 [Abstract] [Full Text] [Related]
7. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif. Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S. J Hum Virol; 1999 Feb 01; 2(2):72-80. PubMed ID: 10225209 [Abstract] [Full Text] [Related]
8. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation. Yurochko AD, Huong SM, Huang ES. J Hum Virol; 1999 Feb 01; 2(2):81-90. PubMed ID: 10225210 [Abstract] [Full Text] [Related]
9. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants. de Arellano ER, Alcamí J, López M, Soriano V, Holguín A. Antiviral Res; 2010 Nov 01; 88(2):152-9. PubMed ID: 20713090 [Abstract] [Full Text] [Related]
10. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. Marcello A, Zoppé M, Giacca M. IUBMB Life; 2001 Mar 01; 51(3):175-81. PubMed ID: 11547919 [Abstract] [Full Text] [Related]
11. Regulation of the human immunodeficiency virus type 1 long terminal repeat: interactions of thyroid hormone receptor with retinoid-X receptor, nuclear factor kappa B, Sp1, and Tat. Desai-Yajnik V, Samuels HH. Trans Assoc Am Physicians; 1993 Mar 01; 106():13-32. PubMed ID: 8036737 [No Abstract] [Full Text] [Related]
12. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors. Zhao C, Chen Y, Park J, Kim JB, Tang H. Biochem Biophys Res Commun; 2004 Sep 17; 322(2):614-22. PubMed ID: 15325274 [Abstract] [Full Text] [Related]
13. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat. Taylor JP, Pomerantz RJ, Oakes JW, Khalili K, Amini S. Oncogene; 1995 Jan 19; 10(2):395-400. PubMed ID: 7838536 [Abstract] [Full Text] [Related]
14. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing. Bohne J, Kräusslich HG. FEBS Lett; 2004 Apr 09; 563(1-3):113-8. PubMed ID: 15063733 [Abstract] [Full Text] [Related]
15. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells. Thatikunta P, Sawaya BE, Denisova L, Cole C, Yusibova G, Johnson EM, Khalili K, Amini S. J Cell Biochem; 1997 Dec 15; 67(4):466-77. PubMed ID: 9383706 [Abstract] [Full Text] [Related]
16. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6. Kashanchi F, Thompson J, Sadaie MR, Doniger J, Duvall J, Brady JN, Rosenthal LJ. Virology; 1994 May 15; 201(1):95-106. PubMed ID: 8178493 [Abstract] [Full Text] [Related]
17. HIV-1 tat transcriptional activity is regulated by acetylation. Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, Benkirane M, Van Lint C. EMBO J; 1999 Nov 01; 18(21):6106-18. PubMed ID: 10545121 [Abstract] [Full Text] [Related]
18. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Vlach J, Garcia A, Jacqué JM, Rodriguez MS, Michelson S, Virelizier JL. Virology; 1995 Apr 20; 208(2):753-61. PubMed ID: 7747447 [Abstract] [Full Text] [Related]
19. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2. Dal Monte P, Landini MP, Sinclair J, Virelizier JL, Michelson S. AIDS; 1997 Mar 20; 11(3):297-303. PubMed ID: 9147420 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S. J Virol; 1993 May 20; 67(5):2853-61. PubMed ID: 8386279 [Abstract] [Full Text] [Related] Page: [Next] [New Search]